RBC Capital Initiates Coverage On Guardant Health with Outperform Rating, Announces Price Target of $185
Benzinga Newsdesk 4 months ago
NewsPrice TargetInitiationAnalyst Ratings
RBC Capital analyst Dan Leonard initiates coverage on Guardant Health (NASDAQ:GH) with a Outperform rating and announces Price Target of $185.
RBC Capital analyst Dan Leonard initiates coverage on Guardant Health (NASDAQ:GH) with a Outperform rating and announces Price Target of $185.